BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 17689290)

  • 1. Interleukin-10 and the pathogenesis of human visceral leishmaniasis.
    Nylén S; Sacks D
    Trends Immunol; 2007 Sep; 28(9):378-84. PubMed ID: 17689290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
    Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
    Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 enhances Th1-type responses in human Leishmania donovani infections.
    Ghalib HW; Whittle JA; Kubin M; Hashim FA; el-Hassan AM; Grabstein KH; Trinchieri G; Reed SG
    J Immunol; 1995 May; 154(9):4623-9. PubMed ID: 7722314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
    Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
    Hailu A; van der Poll T; Berhe N; Kager PA
    Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani.
    Hailu A; van Baarle D; Knol GJ; Berhe N; Miedema F; Kager PA
    Clin Immunol; 2005 Nov; 117(2):182-91. PubMed ID: 16125466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
    Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
    Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
    Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
    Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of immunosuppressive therapy on murine Leishmania infantum visceral leishmaniosis.
    Gangneux JP; Chau F; Sulahian A; Derouin F; Garin YJ
    Eur Cytokine Netw; 1999 Dec; 10(4):557-9. PubMed ID: 10586123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis.
    Chamizo C; Moreno J; Alvar J
    Vet Immunol Immunopathol; 2005 Jan; 103(1-2):67-75. PubMed ID: 15626462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.
    Bhowmick S; Ravindran R; Ali N
    Vaccine; 2007 Aug; 25(35):6544-56. PubMed ID: 17655984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.
    Kumari S; Samant M; Misra P; Khare P; Sisodia B; Shasany AK; Dube A
    Vaccine; 2008 Oct; 26(45):5700-11. PubMed ID: 18762224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis.
    d'Ettorre G; Ceccarelli G; Carnevalini M; Forcina G; Zaffiri L; Massetti AP; Mastroianni CM; Vullo V
    Acta Trop; 2006 Aug; 99(1):83-7. PubMed ID: 16962979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
    Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania donovani: influence of anti-leishmanial therapy on expression of lymphocyte function-associated antigen-3 and its relevance to pathogenisis in visceral leishmaniasis.
    Shivam P; Jamal F; Kumari S; Bimal S; Narayan S; Das VN; Pandey K; Gupta AK; Singh D; Verma N; Das P; Singh SK
    Hum Immunol; 2013 Dec; 74(12):1575-8. PubMed ID: 23974052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunopathology of experimental visceral leishmaniasis.
    Kaye PM; Svensson M; Ato M; Maroof A; Polley R; Stager S; Zubairi S; Engwerda CR
    Immunol Rev; 2004 Oct; 201():239-53. PubMed ID: 15361245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.
    Nylén S; Maurya R; Eidsmo L; Manandhar KD; Sundar S; Sacks D
    J Exp Med; 2007 Apr; 204(4):805-17. PubMed ID: 17389235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.